Banner

Poll: What is your first-line approach to emergent presbyopes who wear contact lenses?

Poll

This poll is for optometrists and eyecare professionals, only. It will close on Friday, August 13, 2021.

What is your first-line approach to emergent presbyopes who wear contact lenses?

A. Multifocal contact lenses
B. Monovision contact lenses
C. Low-power readers over single-vision contact lenses
D. Low-power readers over single-vision contact lenses
Related Videos
Brianna Rhue, OD, FAAO
Patrick Mooney, CEO of SpyGlass Pharma
Related Content

FDA approves Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Podcast: Look back at contact lenses in 2020

December 17th 2020

Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US

September 12th 2023

Defocus Media: Know the building blocks for vision therapy

December 17th 2020

Tarsus announces Xdemvy availability at pharmacies nationwide

August 24th 2023

Autism spectrum disorder in children requires patience, flexibility

August 24th 2023

FDA approves Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Podcast: Look back at contact lenses in 2020

December 17th 2020

Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US

September 12th 2023

Defocus Media: Know the building blocks for vision therapy

December 17th 2020

Tarsus announces Xdemvy availability at pharmacies nationwide

August 24th 2023

Autism spectrum disorder in children requires patience, flexibility

August 24th 2023

FDA approves Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

Podcast: Look back at contact lenses in 2020

December 17th 2020

Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US

September 12th 2023

Defocus Media: Know the building blocks for vision therapy

December 17th 2020

Tarsus announces Xdemvy availability at pharmacies nationwide

August 24th 2023

Autism spectrum disorder in children requires patience, flexibility

August 24th 2023
© 2023 MJH Life Sciences

All rights reserved.